Lung Cancer clinical trials in Rhode Island

3 actively recruiting lung cancer trials at 1 site across Rhode Island.

Data from ClinicalTrials.gov · last refreshed 2026-10-01

Phase 3 Recruiting Academic/Other

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC

Sponsor: University of Texas Southwestern Medical Center

NCT ID: NCT02468024

Sites in Rhode Island:

Lifespan Oncology Clinical Research — Providence, Rhode Island

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved,…

Sponsor: InSightec

NCT ID: NCT05317858

Sites in Rhode Island:

Rhode Island Hospital — Providence, Rhode Island

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.

Sponsor: AstraZeneca

NCT ID: NCT06996782

Sites in Rhode Island:

Research Site — Providence, Rhode Island
Research Site — Providence, Rhode Island

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01